The COVID-19 Testing Evidence Co-op
An evidence co-op for discussing diagnostics and sharing testing strategies and shaping best practices.
Scaling up antigen rapid testing combined with rapid deployment of public health measures are needed to slow the spread of Variants of Concern and save lives and livelihoods. This evidence co-op has been established to support better and faster informed decision making based on collectively shared case studies.
This evidence co-op is divided into 4 courses:
-
All Courses, Evidence Co-op
The COVID-19 Evidence Co-op #1: Sharing Antigen Testing Strategies and Shaping Best Practices
14 Activities Free
-
All Courses, Evidence Co-op
The COVID-19 Evidence Co-op #2: Travel & Mass Gathering Events
11 Activities Free
-
All Courses, Evidence Co-op
The COVID-19 Evidence Co-op #3: Testing the Community
19 Activities Free
-
All Courses, Evidence Co-op
The COVID-19 Evidence Co-op #4: School Testing
16 Activities Free
Partners
Working with key regional organizations, such as Africa Centres for Disease Control & Prevention (Africa CDC), Association of Southeast Asian Nations (ASEAN), Latin American Alliance for the Development of In Vitro Diagnostics (ALADDiV), and International Diagnostic Centre/London School of Hygiene & Tropical Medicine (IDC/LSHTM); the Global Health Impact Group (GHIG) is bringing together health and non-health sector stakeholders to keep updated on the use of testing in combination with other public health measures to guide best practices across regions as economies begin to open.
Acknowledgement
Global Health CPD is proud to recognize support for this initiative provided through educational grants from Africa Centres for Disease Control & Prevention (Africa CDC) and Institut Pasteur de Dakar (IPD).